JP4662867B2 - Attachment for mixing - Google Patents

Attachment for mixing

Info

Publication number
JP4662867B2
JP4662867B2 JP2006063230A JP2006063230A JP4662867B2 JP 4662867 B2 JP4662867 B2 JP 4662867B2 JP 2006063230 A JP2006063230 A JP 2006063230A JP 2006063230 A JP2006063230 A JP 2006063230A JP 4662867 B2 JP4662867 B2 JP 4662867B2
Authority
JP
Japan
Prior art keywords
mixing
medicine
storage chamber
raw water
attachment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2006063230A
Other languages
Japanese (ja)
Other versions
JP2007237083A (en
Inventor
敏男 渡辺
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Priority to JP2006063230A priority Critical patent/JP4662867B2/en
Publication of JP2007237083A publication Critical patent/JP2007237083A/en
Application granted granted Critical
Publication of JP4662867B2 publication Critical patent/JP4662867B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Description

本発明は、薬剤収容室に収容された混合用薬剤を原水に混合しつつ、該原水と共に流出させる混合用アタッチメント、及び該混合用アタッチメントを一体として取り付けた薬剤散布器具に関する。   The present invention relates to a mixing attachment that mixes a mixing medicine accommodated in a medicine storage chamber with raw water and flows it out together with the raw water, and a medicine spraying device to which the mixing attachment is integrally attached.

例えばシャワー器具等の散布器具において、ホース等の管路を経て供給される原水に入浴剤等の薬剤を混合用薬剤として添加混合し、これらの混合用薬剤とともに原水を散布器具から散布できるようにしたアタッチメントが開示されている(例えば、特許文献1、特許文献2参照)。   For example, in a spraying device such as a shower device, a chemical such as a bathing agent is added and mixed as a mixing agent to the raw water supplied via a pipe such as a hose, and the raw water can be sprayed from the spraying device together with the mixing agent. An attached attachment is disclosed (for example, see Patent Document 1 and Patent Document 2).

特許文献1に記載のアタッチメントは、図7に示すように、外部容器60の内部に薬剤収容室としての内部容器61が設けられた2重構造を備えており、ホース等の管路や、各種の散布器具に取り付けて使用されるものである。そして、内部容器61には混合用薬剤が収容されており、内部容器61の入液口62に設けられたバルブ63を開閉して原水を内部に流入させ、流入した原水により混合用薬剤を溶解又は希釈しつつ常時開放の流出口64を介して原水を流出させて、原水流路65を通過する原水に合流させることにより、混合用薬剤が添加混合された状態で原水を散布器具から散布できるようにするものである。   As shown in FIG. 7, the attachment described in Patent Document 1 includes a double structure in which an internal container 61 serving as a medicine storage chamber is provided inside an external container 60. It is used by attaching to the spraying equipment. The mixing agent is stored in the inner container 61. The valve 63 provided at the liquid inlet 62 of the inner container 61 is opened and closed to allow the raw water to flow into the inside, and the mixing chemical is dissolved by the flowing raw water. Alternatively, by diluting the raw water through the outlet 64 that is always open while diluting and joining the raw water passing through the raw water flow path 65, the raw water can be sprayed from the spraying device in a state where the mixing agent is added and mixed. It is what you want to do.

また、特許文献2に記載のアタッチメントは、内側筒体と外側筒体からなる二重構造を備え、内側筒体の内側を主通水路(原水流路)とすると共に、内側筒体と外側筒体との間を副通水路(薬剤収容室)とし、薬剤収容室の内部に水によって溶出する固形化された化粧剤を封入してなるものである。そして、特許文献2に記載のアタッチメントによれば、配水板の通水孔を介して薬剤収容室に原水を導入し、この導入した原水によって固形化された化粧剤を溶出させつつ常時開放の出口から排出して、主通水路を流れる原水と共に流下させるものである。
特開平8−187454号公報 実開平6−81389号公報
The attachment described in Patent Document 2 includes a double structure including an inner cylinder and an outer cylinder, and the inside of the inner cylinder serves as a main water passage (raw water channel), and the inner cylinder and the outer cylinder. A secondary water passage (drug storage chamber) is formed between the body and the inside of the drug storage chamber is filled with a solidified cosmetic agent eluted by water. Then, according to the attachment described in Patent Document 2, the raw water is introduced into the medicine storage chamber through the water passage hole of the water distribution plate, and the outlet that is always open while the cosmetic agent solidified by the introduced raw water is eluted. It is discharged from the water and flows down together with the raw water flowing through the main channel.
JP-A-8-187454 Japanese Utility Model Publication No. 6-81389

一方、例えばシャワー器具に薬剤混合用のアタッチメントを取り付けて用いる場合、シャワー水に混合される薬剤を所望の濃度に保持しつつ、所望の時間継続して薬剤を徐放させるようにすることが好ましく、また薬剤収容室に収容された薬剤を、残すことなく所望の時間内にその略全部を使い切って、効率良く薬剤を散布できるようにすることが好ましい。   On the other hand, for example, when an attachment for mixing medicine is attached to a shower device, it is preferable to keep the medicine mixed in the shower water at a desired concentration and to release the medicine continuously for a desired time. In addition, it is preferable that the medicine stored in the medicine storage chamber is used up in a desired time without leaving the medicine, and the medicine can be efficiently sprayed.

しかしながら、従来の薬剤混合用のアタッチメントによれば、特に例えば2000〜30000mPa・sec程度の粘度の薬剤を薬剤収容室に収容して用いる場合や、薬剤収容室に流入する原水が低水量(3L/分以下)の場合、或いはパウダー入りの薬剤を用いる場合等においては、薬剤収容室内の薬剤が原水に混合され難くなり、特に流速が遅くなる薬剤収容室の壁面近傍部分の薬剤が、徐放されることなく剤残りを生じやすくなる。そして、このような薬剤の剤残りや剤残りの累積によって、特に長期間に亘ってアタッチメントを用いる場合には、アタッチメントが汚れて内部が見難くなり、見栄えが悪くなると共に、薬剤の無駄を生じ、また予定していた所望の徐放時間を十分に確保できなくなって薬剤による効果が十分に得られなくなる。   However, according to the conventional attachment for mixing drugs, for example, when a drug having a viscosity of about 2000 to 30000 mPa · sec is stored in the drug storage chamber, or when the raw water flowing into the drug storage chamber is low in volume (3 L / In the case of using a powdered medicine or the like, the medicine in the medicine containing chamber becomes difficult to be mixed with raw water, and the medicine in the vicinity of the wall of the medicine containing room where the flow rate is slow is gradually released. It becomes easy to produce the agent residue without. And, when using an attachment over a long period of time due to such drug residue or accumulation of the drug residue, the attachment becomes dirty and the inside becomes difficult to see, and the appearance becomes poor and waste of the drug occurs. In addition, the desired desired sustained release time cannot be sufficiently secured, and the effect of the drug cannot be sufficiently obtained.

本発明は、例えば高い粘度の薬剤を用いる場合や、薬剤収容室に流入する原水が低水量の場合、或いはパウダー入りの薬剤を用いる場合でも、剤残りが生じるのを効果的に抑制して薬剤収容室に収容された混合用薬剤を効率良く使用できると共に、所望の濃度で所望の時間継続して薬剤を徐放させつつ原水に混合させることのできる混合用アタッチメント、及び該混合用アタッチメントを取り付けた薬剤散布器具を提供することを目的とする。   The present invention effectively suppresses the generation of a residual agent even when, for example, a high-viscosity drug is used, when the raw water flowing into the drug storage chamber is low, or when a powdered drug is used. A mixing attachment capable of efficiently using the mixing agent stored in the storage chamber and mixing the raw drug with raw water while continuously releasing the drug at a desired concentration for a desired time, and the mixing attachment attached The purpose is to provide a chemical spraying device.

本発明は、内側筒体と外側筒体とを有し、前記内側筒体の内側を原水主流路とすると共に、前記内側筒体と前記外側筒体との間の中空部を、両端を上流側閉塞部と下流側閉塞部とで覆って円環状断面の薬剤収容室とし、該薬剤収容室に収容された混合用薬剤を原水に混合しつつ、該原水と共に流出させる混合用アタッチメントであって、前記薬剤収容室には、前記原水主流路から分岐水路を経て流入する水の流れの作用によって当該薬剤収容室の内部で遊動する、比重の異なる少なくとも2種類の流動子が収容されており、1種類以上の前記流動子は、重心に対し対称であり一対の端面の周縁を結ぶ対角方向の長さが前記薬剤収容室の径方向の幅より長くなっていることにより、前記薬剤収容室の内部で接触面が入れ替わることなく、前記薬剤収容室の内部で遊動する混合用アタッチメント、及び該混合用アタッチメントを一体として取り付けた薬剤散布器具を提供することにより、上記目的を達成したものである。   The present invention has an inner cylindrical body and an outer cylindrical body, the inside of the inner cylindrical body is used as a raw water main flow path, and the hollow portion between the inner cylindrical body and the outer cylindrical body is disposed upstream at both ends. A mixing attachment that is covered with a side blocking portion and a downstream blocking portion to form a medicine storage chamber having an annular cross section, and the mixing agent stored in the drug storage chamber is mixed with the raw water and flows out together with the raw water. The drug storage chamber stores at least two kinds of fluidizers having different specific gravity, which move inside the drug storage chamber by the action of the flow of water flowing from the raw water main channel through the branch channel, The one or more kinds of the fluidizers are symmetrical with respect to the center of gravity, and the length in the diagonal direction connecting the peripheral edges of the pair of end faces is longer than the width in the radial direction of the drug storage chamber. Without changing the contact surface inside Mixing attachment to floating within the housing chamber, and by providing a chemical spraying device fitted integrally to the mixing attachment is obtained by achieving the above object.

本発明の混合用アタッチメント又は薬剤散布器具によれば、例えば高い粘度の薬剤を用いる場合や、薬剤収容室に流入する原水が低水量の場合、或いはパウダー入りの薬剤を用いる場合でも、剤残りが生じるのを効果的に抑制して薬剤収容室に収容された混合用薬剤を効率良く使用できると共に、所望の濃度で所望の時間継続して薬剤を徐放させつつ原水に混合させることができる。   According to the mixing attachment or the medicine spraying device of the present invention, for example, even when a high viscosity medicine is used, the raw water flowing into the medicine storage chamber is low, or even when a powdered medicine is used, the residual medicine remains. It is possible to effectively suppress the generation and use the mixing drug stored in the drug storage chamber, and to mix it with the raw water while continuously releasing the drug at a desired concentration for a desired time.

本発明の好ましい一実施形態に係る混合用アタッチメント10は、図1に示すように、例えば、散布器具であるシャワー器具11と、シャワー水供給ホース12との間に介在して取り付けられ、原水であるシャワー水に浴用薬剤、洗浄用薬剤、香料薬剤、スキンケア用薬剤等の薬剤を添加混合しつつ下流側のシャワー器具11に向けて流下させて、これらの薬剤が添加混合されたシャワー水によってシャワーを行うことを可能にし、シャワー器具11を薬剤散布器具としても用いることができるようにするために採用されたものである。すなわち、本実施形態の混合用アタッチメント10は、例えば合成樹脂からなり、例えば使用者が湯上り用としてシャワーを使用する際に、その都度、薬剤収容室15(図2参照)に所望量(薬剤の1回当たりの使用量が5〜25g)の混合用薬剤を注入充填し、入浴の仕上げとして、例えば10〜60秒間程度、混合用薬剤を徐放させつつシャワー水を身体に散水させ、当該混合用薬剤を身体に付着させて、これらの薬剤による効用が得られるようにすること目的として用いられるものである。   As shown in FIG. 1, the mixing attachment 10 according to a preferred embodiment of the present invention is attached, for example, between a shower device 11, which is a spray device, and a shower water supply hose 12. While showering chemicals such as bathing chemicals, cleaning chemicals, perfume chemicals, skin care chemicals, etc. are added and mixed in a shower water, they are allowed to flow down toward the shower device 11 on the downstream side, and shower water is added and mixed with these chemicals. The shower apparatus 11 is employed to be able to be used as a medicine spraying apparatus. That is, the mixing attachment 10 of the present embodiment is made of, for example, a synthetic resin. For example, each time a user uses a shower for bathing, a desired amount (drug of the drug) is stored in the drug storage chamber 15 (see FIG. 2). Inject and fill the mixing agent at a usage rate of 5 to 25 g at one time. As a bathing finish, for example, for about 10 to 60 seconds, the mixing agent is gradually released and the shower water is sprayed on the body, and the mixing is performed. It is used for the purpose of adhering drugs for use on the body so that the effects of these drugs can be obtained.

そして、本実施形態の混合用アタッチメント10は、図2及び図3(a),(b)に示すように、シャワー水供給ホース12側の原水主流路(上流側流路)13とシャワー器具11側の原水主流路(下流側流路)14との間に介在して設けられ、薬剤収容室15に収容された混合用薬剤を流入口37(図3(b)参照)を介して上流側流路13から流入した原水に混合しつつ、当該混合用薬剤を希釈させた混合液を原水と共に流出口39(図3(b)参照)を介して下流側流路14に流出させるアタッチメントであって、内側筒体16と外側筒体17とを有しており、内側筒体16の内側を原水主流路18とすると共に、内側筒体16と外側筒体17との間の中空部を、両端を上流側閉塞部19と下流側閉塞部20とで覆って円環状断面の薬剤収容室15とし、この薬剤収容室15に収容された混合用薬剤を原水に混合しつつ、原水と共に流出させるようになっている。   And the attachment 10 for mixing of this embodiment is shown in FIG.2 and FIG.3 (a), (b), the raw water main flow path (upstream flow path) 13 by the side of the shower water supply hose 12 and the shower apparatus 11 The mixing chemical contained in the chemical containing chamber 15 is provided upstream from the raw water main flow channel (downstream flow channel) 14 on the upstream side through the inlet 37 (see FIG. 3B). It is an attachment that mixes with the raw water flowing in from the flow path 13 and flows the mixed solution diluted with the mixing agent together with the raw water to the downstream flow path 14 through the outlet 39 (see FIG. 3B). The inner cylindrical body 16 and the outer cylindrical body 17 are provided, and the inner side of the inner cylindrical body 16 is used as a raw water main flow path 18, and a hollow portion between the inner cylindrical body 16 and the outer cylindrical body 17 is formed. A medicine with an annular cross-section covering both ends with an upstream blocking portion 19 and a downstream blocking portion 20 A storage chamber 15, while mixing the mixed agent accommodated in the medicine accommodating chamber 15 to the raw water, so as to flow out together with the raw water.

また、薬剤収容室15には、原水主流路18から原水流入路(分岐水路)21を経て流入する水の流れの作用によって当該薬剤収容室15の内部で遊動する、比重の異なる少なくとも2種類の流動子50a,50b(本実施形体では、2種類又は3種類の流動子が、好ましくは合計3個〜6個)が収容されており、図4(a),(b)にも示すように、1種類以上(本実施形地では2種類又は3種類)の流動子50a,50b,50cは、重心に対し対称となっており、一対の端面55,55の周縁を結ぶ対角方向の長さdが薬剤収容室15の径方向の幅cより長くなっていることにより、薬剤収容室15の内部で接触面(本実施形態では端面55,55)が入れ替わることなく、薬剤収容室の内部で遊動するようになっている。   Further, at least two types having different specific gravity are floated in the medicine storage chamber 15 by the action of water flowing from the raw water main channel 18 through the raw water inflow channel (branch channel) 21 into the drug storage chamber 15. Fluidizers 50a and 50b (in this embodiment, two or three types of fluidizers, preferably a total of three to six) are accommodated, as shown in FIGS. 4 (a) and 4 (b). One or more (two or three types in this embodiment) fluidizers 50a, 50b, 50c are symmetrical with respect to the center of gravity, and are diagonally long connecting the peripheral edges of the pair of end faces 55, 55. Since the length d is longer than the radial width c of the medicine storage chamber 15, the contact surface (the end surfaces 55 and 55 in this embodiment) does not change inside the medicine storage chamber 15, and the inside of the medicine storage chamber. It comes to play with.

また、本実施形態では、1種類以上(本実施形地では2種類又は3種類)の流動子50a,50b,50cは、一対の端面55,55と該端面55,55の間の側周面56とを備える高さの低い柱体形状を有していて、一方の端面55を円環状断面の放射方向外側に向けた状態で薬剤収容室15の内部に収容されており、上述のように一対の端面55,55の周縁を結ぶ対角方向の長さdが薬剤収容室15の径方向の幅cより長くなっていることにより、一方の端面55を円環状断面の放射方向外側に向けた状態を保持しつつ薬剤収容室15の内部で遊動するようになっている。   In the present embodiment, one or more types (two or three types in the present embodiment) of the fluidizers 50a, 50b, and 50c are a pair of end surfaces 55, 55 and a side peripheral surface between the end surfaces 55, 55. 56 and is housed in the medicine containing chamber 15 with one end face 55 facing outward in the radial direction of the annular cross section, as described above. Since the diagonal length d connecting the peripheral edges of the pair of end surfaces 55, 55 is longer than the radial width c of the medicine storage chamber 15, one end surface 55 is directed radially outward of the annular cross section. The inside of the medicine storage chamber 15 is allowed to float while maintaining the above state.

さらに、本実施形態では、流動子50a,50b,50cは、一対の端面55,55と該端面55,55の間の側周面56とを備える高さの低い柱体形状として、高さの低い円柱形状又は略円柱形状を有しており、また各流動子50a,50b,50cは、比重の異なる2種類又は3種類の流動子となっている。   Further, in the present embodiment, the fluidizers 50a, 50b, and 50c have a height as a columnar shape having a low height including a pair of end surfaces 55 and 55 and a side peripheral surface 56 between the end surfaces 55 and 55. Each of the fluidizers 50a, 50b and 50c has two or three types of fluidizers having different specific gravities.

本実施形態の混合用アタッチメント10を構成する内側筒体16は、図2及び図3(a),(b)に示すように、円盤ドーナツ形状の上方基盤32と円盤ドーナツ形状の下方基盤33とによって上下の端部を支持された状態で固定され、内側の原水主流路18は、上方基盤32及び下方基盤33の中央貫通穴32a,33aを介して、シャワー器具11側の原水主流路である下流側流路14やシャワー水供給ホース12側の原水主流路である上流側流路13と連通している。この内側筒体16の下部及び上部における周面が上流側閉塞部19及び下流側閉塞部20によって覆われる部分には、上流側連通孔34及び下流側連通孔35が、当該内側筒体16の周壁を横方向に貫通するようにして、周方向Yの同じ位置に上下に配置されて各々形成されている。   As shown in FIG. 2 and FIGS. 3A and 3B, the inner cylinder 16 constituting the mixing attachment 10 of the present embodiment includes an upper base 32 having a disk donut shape and a lower base 33 having a disk donut shape. The inner raw water main flow path 18 is a raw water main flow path on the shower device 11 side through the central through holes 32a and 33a of the upper base 32 and the lower base 33. It communicates with the downstream flow path 14 and the upstream flow path 13 which is the raw water main flow path on the shower water supply hose 12 side. An upstream side communication hole 34 and a downstream side communication hole 35 are provided on the peripheral surface of the lower side and the upper side of the inner side cylindrical body 16 by the upstream side blocking part 19 and the downstream side blocking part 20. They are formed by being vertically arranged at the same position in the circumferential direction Y so as to penetrate the circumferential wall in the lateral direction.

外側筒体17は、好ましくは透明な合成樹脂からなるスリーブ形状の部材であって、その下端部及び上端部において、内側筒体16との間に上流側閉塞部19及び下流側閉塞部20を各々介在させて、内側筒体16に対して周方向Y(図6(b)参照)に回転移動可能に取り付けられる。これによって、外側筒体17の内側には、当該外側筒体17と、内側筒体16と、上流側閉塞部19及び下流側閉塞部20とによって囲まれる、円環状断面の薬剤収容室15が形成されることになる。   The outer cylindrical body 17 is preferably a sleeve-shaped member made of a transparent synthetic resin, and an upstream side blocking portion 19 and a downstream side blocking portion 20 are provided between the lower end portion and the upper end portion with the inner cylindrical body 16. Each is interposed and attached to the inner cylinder 16 so as to be rotatable in the circumferential direction Y (see FIG. 6B). Thereby, inside the outer cylinder 17, there is an annular cross-section medicine storage chamber 15 surrounded by the outer cylinder 17, the inner cylinder 16, the upstream blocking part 19 and the downstream blocking part 20. Will be formed.

なお、本実施形態によれば、外側筒体17には、これの下部における周面に薬剤収容室15への薬剤注入口23が開口形成され、この薬剤注入口23は水抜き口を兼ねると共に、外側筒体17の上部には、薬剤注入口23の垂直上方に位置して空気孔36が開口形成されている。そして、薬剤注入口23及び空気孔36を覆うようにして、これらと同時に合致可能なスライド注入口24及びスライド空気孔43を有する開閉スライド部材25が、外側筒体17の軸方向Xにスライド移動可能に取り付けられている(図6(a),(b)参照)。   According to the present embodiment, the outer cylinder 17 is provided with the medicine injection port 23 to the drug storage chamber 15 on the peripheral surface at the lower portion thereof, and the drug injection port 23 also serves as a drainage port. An air hole 36 is formed in the upper portion of the outer cylinder 17 so as to be positioned vertically above the drug injection port 23. Then, the open / close slide member 25 having the slide inlet 24 and the slide air hole 43 that can coincide with the medicine inlet 23 and the air hole 36 is slid in the axial direction X of the outer cylinder 17. It is attached so as to be possible (see FIGS. 6A and 6B).

外側筒体17と内側筒体16との間に介在する上流側閉塞部19と下流側閉塞部20は、円盤ドーナツ形状の部材であって、下方基盤33と上方基盤32の薬剤収容室15側の内面に各々回転スライド可能に密着して取り付けられる。また上流側閉塞部19と下流側閉塞部20は、シール性を確保するためのO−リングを適宜の位置に介在させつつ、上流側閉塞部19と下流側閉塞部20の外周面を外側筒体17の内周面に各々接合一体化すると共に、これらの内周面を内側筒体16の外周面に各々回転スライド可能に密着させて取り付けられる。これによって上流側閉塞部19と下流側閉塞部20は、内側筒体16を中心とした周方向Yに、外側筒体17と一体となって回転移動することになる。   An upstream side blocking portion 19 and a downstream side blocking portion 20 interposed between the outer cylinder body 17 and the inner cylinder body 16 are disk-shaped donut-shaped members, and are on the side of the medicine container 15 of the lower base 33 and the upper base 32. Are attached in close contact with each other so as to be slidable. Further, the upstream side blocking portion 19 and the downstream side blocking portion 20 are provided with the outer peripheral surfaces of the upstream side blocking portion 19 and the downstream side blocking portion 20 on the outer cylinder while interposing an O-ring for ensuring sealing performance at an appropriate position. The inner peripheral surfaces of the body 17 are joined and integrated, and these inner peripheral surfaces are attached to the outer peripheral surface of the inner cylindrical body 16 so as to be slidably rotatable. As a result, the upstream blocking portion 19 and the downstream blocking portion 20 rotate together with the outer cylinder 17 in the circumferential direction Y around the inner cylinder 16.

また、円盤ドーナツ形状の上流側閉塞部19と下流側閉塞部20の内部には、これらの断面中央部分を同心状かつ円環状に貫通するようにして、原水流入路(分岐水路)21及び流出路(分岐水路)22が、周方向Yに沿って延設して各々形成されている。原水流入路21が形成された上流側閉塞部19には、内側筒体16の上流側連通孔34と合致することが可能な周方向Yの特定の位置に、内側筒体16の外周面を覆う当該上流側閉塞部19の内壁部分を貫通して、流入口37(図3(b)参照)が形成されている。また原水流入路21の天面壁部分を貫通して、収容室連通孔38が周方向Yに複数箇所開口形成されており、これらの収容室連通孔38を介して、原水流入路21から薬剤収容室15に原水を供給することができるようになっている。   Further, in the upstream side blocking part 19 and the downstream side blocking part 20 in the shape of a disk donut, the raw water inflow channel (branch channel) 21 and the outflow are formed so as to penetrate the central part of the cross section concentrically and in an annular shape. Channels (branch water channels) 22 are formed extending along the circumferential direction Y, respectively. In the upstream side blocking portion 19 where the raw water inflow passage 21 is formed, the outer peripheral surface of the inner cylindrical body 16 is placed at a specific position in the circumferential direction Y that can match the upstream communication hole 34 of the inner cylindrical body 16. An inflow port 37 (see FIG. 3B) is formed through the inner wall portion of the upstream blocking portion 19 to be covered. Further, through the top wall portion of the raw water inflow passage 21, a plurality of storage chamber communication holes 38 are formed in the circumferential direction Y, and the medicine is stored from the raw water inflow passage 21 through these storage chamber communication holes 38. Raw water can be supplied to the chamber 15.

一方、流出路22が形成された下流側閉塞部20には、内側筒体16の下流側連通孔35と合致することが可能な周方向Yの特定の位置に、内側筒体16の外周面を覆う当該下流側閉塞部20の内壁部分を貫通して、流出口39(図3(b)参照)が、流入口37と同じ方向に開口して形成されている。また流出路22の下面壁部分を貫通して、収容室連通孔40が周方向Yに複数箇所開口形成されており、これらの収容室連通孔40を介して、混合用薬剤を混入した原水を薬剤収容室15から流出路22に排出することができるようになっている。   On the other hand, in the downstream blocking portion 20 where the outflow path 22 is formed, the outer peripheral surface of the inner cylinder 16 is located at a specific position in the circumferential direction Y that can match the downstream communication hole 35 of the inner cylinder 16. An outflow port 39 (see FIG. 3B) is formed so as to open in the same direction as the inflow port 37 so as to penetrate the inner wall portion of the downstream blocking portion 20 covering the same. A plurality of storage chamber communication holes 40 are formed in the circumferential direction Y so as to penetrate the lower wall portion of the outflow passage 22, and the raw water mixed with the mixing agent is passed through these storage chamber communication holes 40. The medicine can be discharged from the medicine storage chamber 15 to the outflow path 22.

そして、本実施形態によれば、内側筒体16に対する、上流側閉塞部19及び下流側閉塞部20が一体となった外側筒体17の相対的な回転移動によって、図3(a)に示すような、上流側連通孔34及び下流側連通孔35と、流入口37及び流出口39とが互いにずれて原水流入路21及び流出路22が閉塞された状態と、図3(b)に示すような、上流側連通孔34及び下流側連通孔35と、流入口37及び流出口39とが互いに合致して原水流入路21及び流出路22が開放された状態とを切り替えて、原水流入路21及び流出路22の開閉操作を容易に行うことが可能になる。   And according to this embodiment, it shows to Fig.3 (a) by the relative rotational movement of the outer side cylinder 17 with which the upstream side blocking part 19 and the downstream side blocking part 20 were united with respect to the inner side cylinder 16. FIG. FIG. 3B shows a state in which the upstream communication hole 34 and the downstream communication hole 35, the inlet 37 and the outlet 39 are displaced from each other, and the raw water inlet 21 and outlet 22 are closed. The raw water inflow channel is switched between the upstream communication hole 34 and the downstream communication hole 35, the inlet 37 and the outlet 39, and the raw water inflow channel 21 and the outflow channel 22 being opened. It is possible to easily perform the opening / closing operation of 21 and the outflow path 22.

本実施形態によれば、薬剤収容室15の内部に収容される流動子50a,50b,50cは、例えばプラスチックからなり、図4(a),(b)に示すように、両側の一対の端面55,55の径(直径)aが4.5〜12mm程度、これらの一対の端面51,51に挟まれる側周面56の高さbが3〜4.7mm程度の大きさの、高さbの低い円柱形状又は略円柱形状の部材である。また流動子50a,50b,50cの比重は、薬剤収容室15に収容される混合用薬剤、或いは薬剤収容室15に流入する原水の比重の1〜3倍程度であることが好ましく、本実施形態では、異なる比重として、例えば流動子50aの比重が1.0、流動子50bの比重が1.1、流動子50cの比重が1.3となっている。   According to this embodiment, the fluidizers 50a, 50b, and 50c accommodated in the medicine accommodating chamber 15 are made of, for example, plastic, and a pair of end surfaces on both sides as shown in FIGS. 55, 55 has a diameter (diameter) of about 4.5 to 12 mm, and a height b of the side peripheral surface 56 sandwiched between the pair of end surfaces 51 and 51 is about 3 to 4.7 mm. It is a member having a columnar shape or a substantially cylindrical shape with a low b. Moreover, the specific gravity of the fluidizers 50a, 50b, and 50c is preferably about 1 to 3 times the specific gravity of the mixing drug stored in the drug storage chamber 15 or the raw water flowing into the drug storage chamber 15. In this case, for example, the specific gravity of the fluidizer 50a is 1.0, the specific gravity of the fluidizer 50b is 1.1, and the specific gravity of the fluidizer 50c is 1.3.

流動子50a,50b,50cは、流入口37から流出口39へ向かう水の流れの作用によって、薬剤収容室15の内部において、特に外側筒体17の内壁面に衝突しながら当該内壁面の近傍部分の薬剤を掻き取るようにして徐放させつつ、上下左右にあばれるようにして自由に動く(遊動する)ことになる。   The fluidizers 50a, 50b, and 50c are located in the vicinity of the inner wall surface while colliding with the inner wall surface of the outer cylindrical body 17 in the medicine containing chamber 15 by the action of the water flow from the inlet 37 to the outlet 39. The drug is moved freely (moved) so as to be lifted up, down, left and right while being gradually released by scraping off the drug of the part.

本実施形態では、流動子50a,50b,50cは、柱体形状の一対の端面55の周縁を結ぶ対角方向の長さd(図4(b)参照)が薬剤収容室15の径方向の幅c(図4(a)参照)より長くなっていることにより、一方の端面55を円環状断面の薬剤収容室15の放射方向外側に向けた状態に保ったまま薬剤収容室15の内部で遊動するので、外側筒体17の内壁面と対向配置されることにより接触面となる当該一方の端面55及びこれの周縁の角部によって、接触面が入れ替わることなく、効率良く薬剤収容室15に収容された薬剤を徐放させることが可能になる。なお、一方の端面55を円環状断面の薬剤収容室15の放射方向外側に向けた状態には、一方の端面55が円環状断面の中心からの放射方向に向けて正確に配置された状態の他、流動子50a,50b,50cの側周面52を外側筒体17の内壁面と対向させない範囲で、一方の端面55が円環状断面の中心からの放射方向と相当程度ずれた方向を向いて配置された状態も含まれる。   In the present embodiment, the fluidizers 50 a, 50 b, and 50 c have diagonal lengths d (see FIG. 4B) connecting the peripheral edges of the pair of columnar end surfaces 55 in the radial direction of the medicine container 15. By being longer than the width c (see FIG. 4 (a)), one end face 55 is kept inside the medicine container 15 while keeping the one end face 55 radially outward of the medicine container 15 having an annular cross section. Since it floats, the contact surface is not replaced by the one end surface 55 that becomes a contact surface by being opposed to the inner wall surface of the outer cylindrical body 17 and the peripheral corners thereof, and the medicine container 15 is efficiently replaced. It becomes possible to release the contained medicine gradually. In the state where one end face 55 is directed outward in the radial direction of the medicine storage chamber 15 having an annular cross section, one end face 55 is accurately disposed in the radial direction from the center of the annular cross section. In addition, one end face 55 faces a direction that is considerably deviated from the radial direction from the center of the annular cross section in a range in which the side peripheral surface 52 of the fluidizer 50a, 50b, 50c is not opposed to the inner wall surface of the outer cylindrical body 17. It is also included in the state of being arranged.

また、本実施形態では、2種類又は3種類の異なる比重の流動子50a,50b,50cが薬剤収容室15の内部に収容されており、これらの流動子50a,50b,50cは、流入口37から流出口39へ向かう水の流れの作用によって、薬剤収容室15において上下に略均等に2分割或いは3分割された領域に分散保持された状態で遊動することになるので、偏りを生じることなく薬剤収容室15の略全体に亘って効率良く薬剤を徐放させることが可能になる。   In the present embodiment, two or three different specific gravity fluids 50a, 50b, and 50c are accommodated in the medicine accommodating chamber 15, and these fluids 50a, 50b, and 50c are inflow ports 37. By the action of the flow of water from the outlet 39 to the outlet 39, the medicine storage chamber 15 is floated in a state of being distributed and held in two or three divided areas approximately evenly up and down without causing a bias. It is possible to efficiently and slowly release the drug over substantially the entire drug storage chamber 15.

さらに、本実施形態では、流動子50a,50b,50cは、その大きさの大きい方が薬剤の掻き取り効果が大きくなる一方で、大きくなりすぎると薬剤収容室15の壁面に引っ掛かって遊動が停止したり、遊動し難くなり、薬剤の掻き取り効果がかえって低下することから、円環状断面の薬剤収容室15の径方向の幅cと流動子50a,50b,50cの側周面56の高さbとの比b/cは、0.75〜0.83とすることが好ましい。薬剤収容室15の幅cと流動子50a,50b,50cの高さbとの比b/cを0.75〜0.83とすることにより、薬剤の掻き取り効果が大きくなるという利点が得られる。また流動子50a,50b,50cの径aと、側周面の高さbとの比b/aを0.45〜0.9とすることが好ましい。流動子50a,50b,50cの端面55の径aと高さbとの比b/aを0.45〜0.9とすることにより、壁面に引っ掛かって遊動が停止したり、遊動し難くなるのを効果的に回避できるという利点が得られる。   Furthermore, in this embodiment, the larger the size of the fluidizers 50a, 50b, and 50c, the greater the effect of scraping off the drug. Since the effect of scraping the medicine is reduced, the width c in the radial direction of the medicine storage chamber 15 having an annular cross section and the height of the side peripheral surface 56 of the fluidizers 50a, 50b, 50c are reduced. The ratio b / c to b is preferably 0.75 to 0.83. By setting the ratio b / c between the width c of the medicine container 15 and the height b of the fluidizers 50a, 50b, and 50c to 0.75 to 0.83, there is an advantage that the effect of scraping the medicine is increased. It is done. Moreover, it is preferable that ratio b / a of the diameter a of the fluidizers 50a, 50b, and 50c and the height b of the side peripheral surface be 0.45 to 0.9. By setting the ratio b / a of the diameter a to the height b of the end faces 55 of the flowers 50a, 50b, and 50c to 0.45 to 0.9, the movement is stopped or it is difficult to move. The advantage that this can be effectively avoided is obtained.

なお、本実施形態では、流動子50a,50b,50cの円柱形状又は略円柱形状の外形には、例えば一対の端面55,55に挟まれる側周面56が、内側に凹んだ凹曲面や、外側に盛り上がった凸曲面等となったものなども含まれる。また、本発明では、流動子の高さの低い柱体形状は、円柱形状又は略円柱形状に限定されることなく、一対の端面と該端面の間の側周面とを備える形状として、例えば楕円柱形状、4角柱形状、多角柱形状等であっても良い。この場合の流動子の端面の径は、当該端面の形状の断面2次半径の2倍を意味するものである。   In the present embodiment, the outer shape of the columnar shape or the substantially cylindrical shape of the fluidizers 50a, 50b, 50c is, for example, a concave curved surface in which a side peripheral surface 56 sandwiched between a pair of end surfaces 55, 55 is recessed inward, Also included are convex curved surfaces that swell outward. In the present invention, the columnar shape having a low height of the fluidizer is not limited to a columnar shape or a substantially columnar shape, and includes a pair of end surfaces and a side peripheral surface between the end surfaces, for example, An elliptical column shape, a quadrangular column shape, a polygonal column shape or the like may be used. In this case, the diameter of the end face of the fluidizer means twice the cross-sectional secondary radius of the shape of the end face.

本実施形態によれば、さらに、混合用アタッチメント10は、薬剤収容室15に不規則な水の流れを生じさせる乱流発生手段57(図3(a),(b)参照)を備えており、これによって、薬剤収容室15の内部の全体に亘って、流動子50a,50bをさらにランダムに遊動させることができるようになっている。すなわち、乱流発生手段57は、例えば図5に示すように、周方向を向いた切欠き面51に周方向放流口52を開口形成した放流羽53を、周方向に180度ずらして2箇所に配置してなる螺旋流発生手段と、各切欠き面51から周方向に90度ずれた2箇所において、放流羽53の外周面に近接して上方に向けて開口形成された軸方向放流口54による軸方向放流手段とによって構成される。   According to this embodiment, the mixing attachment 10 further includes turbulent flow generation means 57 (see FIGS. 3A and 3B) that generates an irregular flow of water in the medicine storage chamber 15. As a result, the fluidizers 50a and 50b can be moved more randomly over the entire interior of the medicine storage chamber 15. That is, as shown in FIG. 5, for example, the turbulent flow generating means 57 includes two discharge wings 53 that are formed by opening a circumferential discharge port 52 on a notch surface 51 that faces in the circumferential direction and is shifted 180 degrees in the circumferential direction. And an axial outlet opening that is open upward and close to the outer peripheral surface of the discharge vane 53 at two locations that are 90 degrees apart from each notch surface 51 in the circumferential direction. 54 and axial discharge means.

そして、螺旋流発生手段の周方向放流口52と軸方向放流手段の軸方向放流口54は、各々上流側閉塞部19の収容室連通孔38を介して原水流入路21と連通しており、流入口37及び流出口39が開放された際に原水流入路21に流入する原水の圧力によって、当該原水を螺旋方向と軸方向に向けて同時に放流させる。これによって、螺旋方向の流れと軸方向の流れとが混合された不規則な流れ(乱流)を、薬剤収容室15の内部に容易に生じさせることができるようになっている。   The circumferential discharge port 52 of the spiral flow generating means and the axial discharge port 54 of the axial discharge means communicate with the raw water inflow passage 21 through the accommodation chamber communication hole 38 of the upstream side blocking portion 19, respectively. When the inlet 37 and the outlet 39 are opened, the raw water is discharged simultaneously in the spiral direction and the axial direction by the pressure of the raw water flowing into the raw water inflow path 21. As a result, an irregular flow (turbulent flow) in which the spiral flow and the axial flow are mixed can be easily generated in the medicine containing chamber 15.

また、本実施形態によれば、混合用アタッチメント10は、図3(a),(b)及び図6(a),(b)に示すように、開閉スライド部材25を軸方向Xにスライド移動させて薬剤注入口23とスライド注入口24とを合致させた状態では(図3(a),図6(a)参照)、内側筒体16に対する外側筒体17の周方向Yへの回転移動を阻止し、外側筒体17を回転移動させて原水流入路21や流出路22が開放された状態では(図3(b),図6(b)参照)、開閉スライド部材25の軸方向Xへのスライド移動を阻止するロック機構を備えている。   Further, according to the present embodiment, the mixing attachment 10 slides the opening / closing slide member 25 in the axial direction X as shown in FIGS. 3 (a) and 3 (b) and FIGS. 6 (a) and 6 (b). When the drug injection port 23 and the slide injection port 24 are matched (see FIGS. 3A and 6A), the outer cylinder 17 rotates in the circumferential direction Y with respect to the inner cylinder 16. In the state in which the outer cylindrical body 17 is rotated and moved to open the raw water inflow path 21 and the outflow path 22 (see FIGS. 3B and 6B), the axial direction X of the open / close slide member 25 A locking mechanism is provided to prevent the sliding movement to.

すなわち、開閉スライド部材25は、外側筒体17の下端縁部から下方に突出可能にスライド移動できるように取り付けられており、ロック機構は、この開閉スライド部材25と、外側筒体17の下方において開閉スライド部材25の下端部である下方突出部分25aを係止する切り欠き凹部26と、外側筒体17の上方に設けられた、遊嵌凸部27及びこの遊嵌凸部27を周方向Yにスライド移動可能に遊嵌する切り欠き凹溝28とによって構成される。そして、開閉スライド部材25の下方突出部分25aを切り欠き凹部26に係止した状態(図6(a)参照)で薬剤注入口23とスライド注入口24とを合致させ、この係止した状態を開放して遊嵌凸部27が切り欠き凹溝28の一方(右側)の端部に当接するまで外側筒体17を回転させることにより(図6(b)参照)、原水流入路21や流出路22を開放するようになっている。   That is, the open / close slide member 25 is attached so as to be slidably movable downward from the lower end edge of the outer cylindrical body 17, and the lock mechanism is provided below the open / close slide member 25 and the outer cylindrical body 17. A notch recess 26 that locks the downward projecting portion 25a that is the lower end portion of the opening / closing slide member 25, a loose fitting convex portion 27 provided above the outer cylindrical body 17, and the loose fitting convex portion 27 in the circumferential direction Y. And a cut-out concave groove 28 that is slidably fitted to be slidable. Then, the medicine injection port 23 and the slide injection port 24 are matched with each other in a state where the downward projecting portion 25a of the opening / closing slide member 25 is notched and locked to the recess 26 (see FIG. 6A), and this locked state is set. By rotating the outer cylindrical body 17 until the loosely fitting convex portion 27 is opened and abuts one end (right side) of the cutout concave groove 28 (see FIG. 6B), the raw water inflow passage 21 and the outflow The path 22 is opened.

また、本実施形態によれば、外側筒体17は、当該外側筒体17の上方及び下方に設けられた上方環状突壁29と下方環状突壁30との間に配置されてこれらに対して周方向Yに回転可能に取り付けられており、切り欠き凹部26は、下方環状突壁30の上端縁部を切り欠いて形成され、切り欠き凹溝28は、上方環状突壁29の下端縁部を切り欠いて形成されている。   Further, according to the present embodiment, the outer cylindrical body 17 is disposed between the upper annular projecting wall 29 and the lower annular projecting wall 30 provided above and below the outer cylindrical body 17 and against these. The notched recess 26 is formed by cutting out the upper edge of the lower annular protruding wall 30, and the notched groove 28 is formed at the lower edge of the upper annular protruding wall 29. It is formed by cutting away.

さらに、本実施形態によれば、外側筒体17の周面には、外側筒体17の軸方向Xに延設するスライド案内溝31が形成されており、開閉スライド部材25は、このスライド案内溝31に填め込まれて当該スライド案内溝31に沿って軸方向Xにスライド移動するようになっている。   Furthermore, according to the present embodiment, the slide guide groove 31 extending in the axial direction X of the outer cylinder 17 is formed on the peripheral surface of the outer cylinder 17, and the open / close slide member 25 is provided with this slide guide. It is inserted into the groove 31 and slides in the axial direction X along the slide guide groove 31.

そして、上述の構成を有する本実施形態の混合用アタッチメント10が取り付けられたシャワー器具11を用いて、混合用薬剤を混合したシャワー水によるシャワーを行うには、まず薬剤収容室15に所望量の混合用薬剤を注入する作業を行う。すなわち、混合用アタッチメント10やシャワー器具11が一体として取り付けられた、図1に示す薬剤散布器具を手で把持し、例えば親指を開閉スライド部材25の隆起部25cに密着係止して、遊嵌凸部27が切り欠き凹溝28の左側端部に当接するまで外側筒体17を回転移動し、さらに開閉スライド部材25を下方にスライド移動して、下方突出部分25aを切り欠き凹部26に係止する。これによって、外側筒体17の薬剤注入口23及び空気孔36と、開閉スライド部材25のスライド注入口24及びスライド空気孔43とが合致するので、空気孔36から空気を排除しつつ、薬剤注入口23を介して薬剤収容室15へ、例えば2000〜30000mPa・sec程度の粘度を有する混合用薬剤をスムーズに注入してゆくことが可能になる。またこの注入作業の最中には、下方突出部分25aの切り欠き凹部26への係止によって、外側筒体17の回転移動が阻止されて、薬剤収容室15に原水を流入させることがない。なお、混合用薬剤の粘度の測定条件は、使用機器:BM型粘度計((株)東京什器製)、ローター:No.4、回転数:12rpm、測定時間:60秒、測定温度:25℃である。   In order to perform a shower using shower water mixed with a mixing agent, using the shower device 11 to which the mixing attachment 10 of the present embodiment having the above-described configuration is attached, first, a desired amount is stored in the drug containing chamber 15. Work to inject the drug for mixing. That is, the medicine spraying device shown in FIG. 1 to which the mixing attachment 10 and the shower device 11 are integrally attached is gripped by hand, and for example, the thumb is tightly locked to the raised portion 25c of the opening / closing slide member 25 to loosely fit. The outer cylindrical body 17 is rotationally moved until the convex portion 27 comes into contact with the left end portion of the notch groove 28, and the open / close slide member 25 is further slid downward, and the downward projecting portion 25a is engaged with the notch recess 26. Stop. As a result, the medicine injection port 23 and the air hole 36 of the outer cylindrical body 17 and the slide injection port 24 and the slide air hole 43 of the open / close slide member 25 are matched, so that the drug injection is performed while excluding air from the air hole 36. It is possible to smoothly inject a mixing drug having a viscosity of, for example, about 2000 to 30000 mPa · sec through the inlet 23 into the drug storage chamber 15. During this injection operation, the outer cylindrical body 17 is prevented from rotational movement by the locking of the downward projecting portion 25 a to the notch recess 26, so that the raw water does not flow into the medicine containing chamber 15. In addition, the measurement conditions of the viscosity of the chemical | medical agent for mixing were used apparatus: BM type | mold viscometer (made by Tokyo Seiki Co., Ltd.), rotor: No. 4. Rotation speed: 12 rpm, measurement time: 60 seconds, measurement temperature: 25 ° C.

薬剤収容室15へ混合用薬剤を所望量注入したら、例えば上述と同様の親指の操作によって、開閉スライド部材25を、その上端部25bが切り欠き凹溝28の左側端部の上縁部分に当接するまで上方にスライド移動させる。これによって、外側筒体17の薬剤注入口23及び空気孔36と、開閉スライド部材25のスライド注入口24及びスライド空気孔43とがずれて、薬剤注入口23及び空気孔36が閉塞され、注入された混合用薬剤が薬剤収容室15から洩出することなく内部に収容された、薬剤散布までの待機状態となる。また、開閉スライド部材25を上方にスライド移動させた後に、これの下端部25aが切り欠き凹部26から周方向Yに外れるように外側筒体17を僅かに回転移動させることにより、かかる待機状態において、開閉スライド部材25が下方に移動して混合用薬剤が洩出するのを効果的に回避することが可能になる。   When a desired amount of the medicine for mixing is injected into the medicine storage chamber 15, the opening / closing slide member 25 is applied to the upper edge portion of the left end portion of the notch groove 28 with the upper end portion 25b thereof, for example, by the same thumb operation as described above. Slide it up until it touches. As a result, the drug injection port 23 and the air hole 36 of the outer cylindrical body 17 and the slide injection port 24 and the slide air hole 43 of the open / close slide member 25 are displaced, and the drug injection port 23 and the air hole 36 are closed and injected. The mixed medicine thus prepared is accommodated inside without leaking from the medicine accommodating chamber 15 and is in a standby state until the medicine is sprayed. Further, after sliding the open / close slide member 25 upward, the outer cylindrical body 17 is slightly rotated so that the lower end portion 25a of the open / close slide member 25 is detached from the notch recess 26 in the circumferential direction Y. Thus, it is possible to effectively prevent the mixing medicine from leaking due to the opening / closing slide member 25 moving downward.

このような待機状態から、使用者が、例えば入浴の仕上げとしてシャワー水と共に混合用薬剤を身体に散布する際には、例えばシャワーを行いつつ上述と同様の親指の操作によって、開閉スライド部材25の遊嵌凸部27が切り欠き凹溝28の右側端部に当接するまで外側筒体17を回転移動する。これによって、上流側連通孔34及び下流側連通孔35と流入口37及び流出口39とが互いに合致し、原水を薬剤収容室15に流入させると共に、混合用薬剤を原水に混合させて原水主流路14に流出させることが可能になり、例えば10〜60秒間、混合用薬剤が無くなるまでシャワー水と共に混合用薬剤を身体に散布することが可能になる。   From such a standby state, when the user sprays the mixing agent together with shower water, for example, as a bathing finish, for example, by performing the same thumb operation as described above while performing a shower, The outer cylindrical body 17 is rotated until the loosely fitting convex portion 27 comes into contact with the right end portion of the notched concave groove 28. As a result, the upstream communication hole 34 and the downstream communication hole 35 and the inflow port 37 and the outflow port 39 are matched with each other, and the raw water flows into the medicine storage chamber 15 and the mixing chemical is mixed with the raw water. It becomes possible to make it flow out to the path | route 14, for example, and to mix | blend the chemical | medical agent for mixing with a shower water on a body until the chemical | medical agent for mixing runs out for 10 to 60 seconds.

シャワーが終了したら、例えば上述と同様の親指の操作によって、外側筒体17を反対側に回転移動して遊嵌凸部27を切り欠き凹溝28の左側端部に当接させ、さらに下方突出部分25aが切り欠き凹部26に係止するまで開閉スライド部材25を下方にスライド移動させる。これによって、外側筒体17の薬剤注入口23及び空気孔36と、開閉スライド部材25のスライド注入口24及びスライド空気孔43とが合致して、混合用薬剤と入れ替わった原水が薬剤注入口23を介して薬剤収容室15から水抜き出され、薬剤収容室15へ混合用薬剤を注入してゆくことが可能な状態に復帰することになる。   When the shower is finished, for example, by the same thumb operation as described above, the outer cylindrical body 17 is rotationally moved to the opposite side so that the loosely fitting convex portion 27 is brought into contact with the left end of the concave groove 28 and further protrudes downward. The open / close slide member 25 is slid downward until the portion 25a engages with the notch recess 26. As a result, the drug injection port 23 and the air hole 36 of the outer cylindrical body 17 and the slide injection port 24 and the slide air hole 43 of the open / close slide member 25 are matched, and the raw water replaced with the mixing drug is the drug injection port 23. Then, the water is extracted from the medicine storage chamber 15, and the state returns to a state in which the medicine for mixing can be injected into the medicine storage chamber 15.

そして、本実施形態によれば、混合用薬剤として上述のような粘度の薬剤を使用する場合や、薬剤収容室15に流入する原水が低水量の場合であっても、剤残りが生じるのを抑制して薬剤収容室15に収容された混合用薬剤を効率良く使用できると共に、所望の濃度で所望の時間継続して薬剤を徐放させつつ、安定した状態で原水に混合させることが可能になる。   And according to this embodiment, even when a medicine with the above-mentioned viscosity is used as a medicine for mixing, or even when the raw water flowing into the medicine storage chamber 15 has a low amount of water, a medicine residue is generated. It is possible to efficiently use the mixing medicine contained in the medicine storage chamber 15 while suppressing the medicine continuously at a desired concentration for a desired time and mixing it with raw water in a stable state. Become.

すなわち、本実施形態によれば、薬剤収容室15には、流入口37から流出口39へ向かう水の流れの作用によって内部で遊動する、比重の異なる少なくとも2種類の流動子50a,50b,50cが収容されており、1種類以上の流動子50a,50b,50cは、一対の端面55,55と側周面56とを備える高さの低い柱体形状を有していて、一方の端面55を放射方向外側に向けた状態で薬剤収容室15の内部に収容されており、且つ流動子50a,50b,50cは、重心に対し対称であり一対の端面55,55の周縁を結ぶ対角方向の長さdが薬剤収容室15の径方向の幅cより長くなっていることにより、一方の端面55を放射方向外側に向けた状態を保持しつつ薬剤収容室15の内部で遊動するので、これらの流動子50a,50b,50cは、薬剤収容室15の内部において外側筒体17の内壁面との接触面が入れ替わることなく、あばれるようにして上下左右に自由に動くことにより、例えば薬剤収容室15の壁面に衝突しながら、特に流速が遅くなる外側筒体17の内壁面の近傍部分の薬剤を掻き落とすことによって、剤残りを抑制しつつ混合用薬剤を効率良く徐放させることが可能になる。   That is, according to the present embodiment, at least two kinds of fluidizers 50a, 50b, and 50c having different specific gravities that float inside by the action of the water flow from the inlet 37 to the outlet 39 are provided in the medicine storage chamber 15. The one or more types of fluid elements 50a, 50b, 50c have a low columnar shape including a pair of end surfaces 55, 55 and a side peripheral surface 56, and one end surface 55 Are stored in the medicine storage chamber 15 in a state of facing outward in the radial direction, and the fluidizers 50a, 50b, 50c are symmetrical with respect to the center of gravity and connect the peripheral edges of the pair of end faces 55, 55 diagonally. Since the length d is longer than the width c in the radial direction of the medicine storage chamber 15, it floats inside the medicine storage chamber 15 while maintaining a state in which one end face 55 is directed radially outward. These fluidizers 50a 50b and 50c collide with, for example, the wall of the drug storage chamber 15 by moving freely up and down, left and right without changing the contact surface with the inner wall surface of the outer cylinder 17 inside the drug storage chamber 15. However, by scraping off the drug in the vicinity of the inner wall surface of the outer cylindrical body 17 where the flow rate is particularly slow, it becomes possible to efficiently and slowly release the mixing drug while suppressing the remaining drug.

また、本実施形態によれば、比重の異なる2種類の流動子50a,50b,50cが薬剤収容室15に収容されているので、これらの流動子50a,50b,50cは、流入口37から流出口39へ向かう水の流れの作用によって、薬剤収容室15において上下に略均等に分割された領域に分散保持された状態で遊動することが可能になるので、偏りを生じることなく薬剤収容室15の略全体に亘って効率良く薬剤を徐放させることが可能になる。   In addition, according to the present embodiment, since two types of fluidizers 50 a, 50 b, 50 c having different specific gravities are accommodated in the medicine accommodating chamber 15, these fluidizers 50 a, 50 b, 50 c flow from the inlet 37. By the action of the flow of water toward the outlet 39, it is possible to move in a state of being distributed and held in a substantially equally divided region in the drug storage chamber 15, so that the drug storage chamber 15 is not biased. It is possible to efficiently and slowly release the drug over substantially the whole.

これらによって、薬剤の剤残りや剤残りの累積が効果的に回避されるので、特に長期間に亘って混合用アタッチメント10を用いる場合でも、混合用アタッチメント10が汚れて内部が見難くなったり、見栄えが悪くなったりすることがなく、また薬剤の無駄を生じることなく、予定していた所望の徐放時間を十分に確保して薬剤による十分な効果を安定して得ることが可能になる。   By these, since the accumulation of drug residue and drug residue is effectively avoided, even when the mixing attachment 10 is used particularly for a long period of time, the mixing attachment 10 becomes dirty and the inside becomes difficult to see, It is possible to obtain a sufficient effect of the medicine stably without securing the appearance or waste of the medicine and sufficiently securing the desired desired sustained release time.

さらに、本実施形態によれば、混合用アタッチメント10は、螺旋流発生手段と軸方向放流手段とからなる乱流発生手段を備えているので、薬剤収容室15の内部に不規則な水の流れを容易に形成することが可能になり、これによって、流動子50a,50b,50cをさらにランダム且つあばれるように遊動させることが可能になり、上記の機能を、一層顕著に発揮させることが可能になる。   Furthermore, according to the present embodiment, the mixing attachment 10 includes the turbulent flow generation means including the spiral flow generation means and the axial direction discharge means. It is possible to easily form the fluidizers 50a, 50b, and 50c so that the fluidizers 50a, 50b, and 50c can be further randomized and exposed, and the above functions can be exhibited more remarkably. Become.

なお、本発明は上記実施形態に限定されることなく種々の変更が可能である。例えば、比重の異なる少なくとも2種類の流動子の全てが、一対の端面と該端面の間の側周面とを備える高さの低い柱体形状を有している必要は必ずしもなく、球形、タマゴ形、ビーズ形状、矩形平板形状等のその他の形状の流動子が混在していても良い。また比重の異なる少なくとも2種類の流動子は、一対の端面と該端面の間の側周面とを備える高さの低い柱体形状による同じ比重の1種類の流動子と、これとは比重の異なる柱体形状以外の形状の流動子とを混在させたものであっても良い。   The present invention is not limited to the above-described embodiment, and various modifications can be made. For example, it is not always necessary that at least two kinds of fluidizers having different specific gravities have a low columnar shape including a pair of end surfaces and a side peripheral surface between the end surfaces. A fluidizer having other shapes such as a shape, a bead shape, and a rectangular flat plate shape may be mixed. In addition, at least two kinds of fluidizers having different specific gravities are one kind of fluidizer having the same specific gravity by a columnar shape having a low height and having a pair of end surfaces and a side peripheral surface between the end surfaces, It may be a mixture of fluidizers having shapes other than different columnar shapes.

また、本発明の混合用アタッチメントは、シャワー水に浴用薬剤やスキンケア用薬剤等の身体用薬剤を混合して送り出すものに限定されることなく、シャワー器具以外のその他の薬剤散布器具に取り付けて、各種の液状、ゲル状、粒状、固形状等の家庭用消費薬剤や農業用薬剤等の薬剤を原水に混合するために採用することもできる。さらに、混合用アタッチメントは、シャワー器具とシャワー水供給ホースとの間に介在させて取り付ける必要は必ずしもなく、シャワー器具の外部から見えないように当該シャワー器具に内蔵させて取り付けることもできる。   In addition, the mixing attachment of the present invention is not limited to one that mixes and sends out body medicine such as bath medicine or skin care medicine into shower water, and is attached to other medicine spraying equipment other than shower equipment, Various liquids, gels, granules, solids, etc., such as household consumption drugs and agricultural chemicals can also be used for mixing with raw water. Further, the mixing attachment is not necessarily required to be interposed between the shower device and the shower water supply hose, and can be attached to the shower device so that it cannot be seen from the outside of the shower device.

さらにまた、本発明では、薬剤収容室の内部で接触面が入れ替わることなく流動子が遊動する状態には、例えば図8(a)に示すような、流動子の側周面が円環状断面の放射方向外側に向いた接触面となっている状態も含まれる。また重心に対し対称であり一対の端面の周縁を結ぶ対角方向の長さが薬剤収容室の径方向の幅より長くなっている流動子には、図8(a),(b)に示すような形状のものも含まれる。   Furthermore, in the present invention, in a state where the fluidizer is allowed to move without changing the contact surface inside the drug storage chamber, for example, as shown in FIG. A state where the contact surface faces radially outward is also included. 8A and 8B show a fluidizer that is symmetrical with respect to the center of gravity and that has a diagonal length connecting the peripheral edges of the pair of end faces longer than the radial width of the drug containing chamber. Such shapes are also included.

以下、本発明を実施例及び比較例に基づいてさらに詳細に説明するが、本発明はこれらに限定されるものではない。   EXAMPLES Hereinafter, although this invention is demonstrated further in detail based on an Example and a comparative example, this invention is not limited to these.

〔実施例1〜9〕
上記実施形態の混合用アタッチメントと同様の構成を備えるアタッチメントの薬剤収容室に、表1に示す種類及び数の流動子を収容した実施例1〜9の混合用アタッチメントを、図1に示すシャワー器具に各々取り付け、後述する剤残りの測定方法によって、所定時間の散水後に薬剤収容室に収容された混合用薬剤の剤残り率を評価した。また、後述する流動子の回転トラブル判定方法によって、薬剤収容室において流動子が引っ掛かったり停止することにより十分に遊動しなくなる回転トラブルについて判定した。なお、薬剤収容室の容量を15cc、薬剤収容室の径方向の幅cを実施例5では6.3mm、それ以外は5.6mmとした。剤残り率の評価結果及び回転トラブルの判定結果を表1に示す。
[Examples 1 to 9]
The attachment for mixing of Examples 1-9 which accommodated the kind and number of fluidizers shown in Table 1 in the medicine storage chamber of the attachment having the same configuration as the mixing attachment of the above embodiment, the shower apparatus shown in FIG. The remaining agent rate of the mixing drug accommodated in the drug containing chamber after water spraying for a predetermined time was evaluated by a method for measuring the remaining agent described later. In addition, the rotation trouble determination method described later was used to determine the rotation trouble that does not move sufficiently due to the liquid crystal being caught or stopped in the medicine storage chamber. In addition, the capacity | capacitance of the chemical | medical agent storage chamber was 15 cc, the width c of the radial direction of the chemical | medical agent storage chamber was 6.3 mm in Example 5, and 5.6 mm other than that. Table 1 shows the evaluation result of the remaining agent ratio and the determination result of the rotation trouble.

〔比較例1〜5〕
上記実施形態の混合用アタッチメントと同様の構成を備えるアタッチメントの薬剤収容室に、表1に示す種類及び数の流動子を収容した比較例1〜5の混合用アタッチメントを、図1に示すシャワー器具に各々取り付け、実施例1〜9と同様に、後述する剤残りの測定方法によって、所定時間の散水後に薬剤収容室に収容された混合用薬剤の剤残り率を評価した。また、後述する流動子の回転トラブル判定方法によって、薬剤収容室において流動子が引っ掛かったり停止することにより十分に遊動しなくなる回転トラブルについて判定した。なお、薬剤収容室の容量を15cc、薬剤収容室の径方向の幅cを比較例1〜3では6.3mm、それ以外は5.6mmとした。剤残り率の評価結果及び回転トラブルの判定結果を表1に示す。
[Comparative Examples 1-5]
The attachment for mixing in Comparative Examples 1 to 5 in which the types and number of fluidizers shown in Table 1 are accommodated in the medicine storage chamber of the attachment having the same configuration as that of the attachment for mixing in the above embodiment is the shower device shown in FIG. In the same manner as in Examples 1 to 9, the agent remaining rate of the mixing drug accommodated in the drug accommodating chamber after sprinkling for a predetermined time was evaluated by the method for measuring the agent remaining described later. In addition, the rotation trouble determination method described later was used to determine the rotation trouble that does not move sufficiently due to the liquid crystal being caught or stopped in the medicine storage chamber. In addition, the capacity | capacitance of the chemical | medical agent storage chamber was 15 cc, the width c of the radial direction of the chemical | medical agent storage chamber was 6.3 mm in the comparative examples 1-3, and 5.6 mm was set to others. Table 1 shows the evaluation result of the remaining agent ratio and the determination result of the rotation trouble.

Figure 0004662867
Figure 0004662867

〔剤残り率の測定方法〕
実施例1〜9及び比較例1〜5の混合用アタッチメントの各薬剤収容室に、粘度13000mPa・sec、比重0.93の着色した混合用薬剤を、12g充填収容した直後に、薬剤収容室を側面から写真撮影し、混合用薬剤によって覆われた収容室の内壁の投影面積を計測してその面積をAとする。シャワー水供給ホースから8L/分の流量で原水を各混合用アタッチメントに供給しつつ、原水流入路及び流出路を開放して、原水を薬剤収容室に15秒間通水させた後に、同様に薬剤収容室を側面から写真撮影し、溶け残った混合用薬剤によって覆われた部分の投影面積を計測してその面積をBとする。B/A×100(%)を剤残り率とし、5%未満を「◎」、5%以上10%未満を「○」、10%以上20%未満を「△」、20%以上を「×」として剤残り率を評価する。
[Measurement method of drug residue rate]
Immediately after each of the drug storage chambers of the attachments of Examples 1 to 9 and Comparative Examples 1 to 5 was charged and stored with 12 g of a colored mixing drug having a viscosity of 13000 mPa · sec and a specific gravity of 0.93, the drug storage chamber was opened. A photograph is taken from the side, and the projected area of the inner wall of the storage chamber covered with the mixing agent is measured, and the area is defined as A. After supplying raw water to each attachment for attachment at a flow rate of 8 L / min from the shower water supply hose, the raw water inflow passage and the outflow passage are opened, and the raw water is passed through the medicine storage chamber for 15 seconds. The accommodation chamber is photographed from the side, and the projected area of the part covered with the undissolved mixing agent is measured, and the area is defined as B. B / A × 100 (%) is the residual ratio of the agent, less than 5% is “◎”, 5% to less than 10% is “◯”, 10% to less than 20% is “△”, and 20% or more is “×”. The remaining drug rate is evaluated.

〔流動子の回転トラブル判定方法〕
実施例1〜9及び比較例1〜5の混合用アタッチメントの各薬剤収容室に、粘度13000mPa・sec、比重0.93の着色した混合用薬剤を、12g充填収容した直後に、シャワー水供給ホースから8L/分の流量で原水を各混合用アタッチメントに供給しつつ、原水流入路及び流出路を開放して、原水を薬剤収容室に60秒間通水させたときに、流動子が10秒以内に回転を開始するか否かを確認すると共に、薬剤収容室の内部で遊動せずに引っ掛かったり停止して生じる回転トラブルの回数を測定する。10秒以内に流動子が回転し、回転トラブルの回数が10回中0回の場合を「◎」、10秒以内に流動子が回転し、回転トラブルの回数が10回中1〜2回の場合を「○」、10秒以内に流動子が回転し、回転トラブルの回数が10回中3回以上の場合を「△」、10秒以内に流動子が回転しないか、又は回転トラブルが10回中7回以上の場合を「×」として判定する。
[Judgment method for fluidizer rotation trouble]
A shower water supply hose immediately after 12 g of the mixing agent having a viscosity of 13000 mPa · sec and a specific gravity of 0.93 was charged and accommodated in each of the drug storage chambers of the attachments of Examples 1 to 9 and Comparative Examples 1 to 5 When supplying raw water at a flow rate of 8 L / min to each mixing attachment, opening the raw water inflow path and outflow path and allowing the raw water to pass through the drug storage chamber for 60 seconds, the fluidizer is within 10 seconds. In addition, it is confirmed whether or not rotation is started, and the number of rotation troubles caused by being caught or stopped without moving inside the medicine container is measured. When the fluidizer rotates within 10 seconds and the number of rotation troubles is 0 out of 10, “◎”, the fluidizer rotates within 10 seconds, and the number of rotation troubles is 1 to 2 out of 10 times. If the case is “◯”, the fluidizer rotates within 10 seconds and the number of rotation troubles is 3 or more out of 10 “△”. If the fluidizer does not rotate within 10 seconds, or the rotation trouble is 10 The case of 7 times or more is determined as “x”.

表1に示す剤残り率の評価結果及び回転トラブルの判定結果から、重心に対し対称であり一対の端面の周縁を結ぶ対角方向の長さが薬剤収容室の径方向の幅より長くなっている流動子を薬剤収容室の内部に収容した本発明に係る実施例1〜9の混合用アタッチメントによれば、比較例1〜5の混合用アタッチメントと比較して、剤残りが少なく、回転トラブルの発生も少ないことから、例えば10〜60秒程度の所望の時間内に、剤残りを顕著に少なくして混合用薬剤を効率良く原水に混合してゆくことができ、例えば湯上り用のシャワーを行うのに好適であることが判明する。   From the evaluation result of the agent remaining rate shown in Table 1 and the determination result of the rotation trouble, the diagonal length connecting the peripheral edges of the pair of end faces is longer than the radial width of the drug containing chamber. According to the mixing attachments of Examples 1 to 9 according to the present invention in which the fluidizers housed in the medicine containing chamber are smaller than the mixing attachments of Comparative Examples 1 to 5, and the rotation trouble Therefore, within a desired time of, for example, about 10 to 60 seconds, the remaining amount of the agent can be remarkably reduced and the mixing agent can be efficiently mixed with the raw water. It turns out to be suitable to do.

本発明の好ましい一実施形態に係る混合用アタッチメントをシャワー器具に取り付けて使用する状況を説明する側面図である。It is a side view explaining the condition which attaches and uses the attachment for mixing which concerns on preferable one Embodiment of this invention to a shower apparatus. 本発明の好ましい一実施形態に係る混合用アタッチメントをシャワー器具に取り付けて構成される薬剤散布器具の断面図である。It is sectional drawing of the chemical | medical agent spraying apparatus comprised by attaching the attachment for mixing which concerns on preferable one Embodiment of this invention to a shower apparatus. (a)は、本発明の好ましい一実施形態に係る混合用アタッチメントの、薬剤収容室へ混合用薬剤を注入可能な状態を示す断面図、(b)は、本発明の好ましい一実施形態に係る混合用アタッチメントの、混合用薬剤を原水に混合可能な状態を示す断面図である。(A) is sectional drawing which shows the state which can inject | pour the chemical | medical agent for mixing into the chemical | medical agent storage chamber of the attachment for mixing which concerns on preferable one Embodiment of this invention, (b) concerns on preferable one Embodiment of this invention. It is sectional drawing which shows the state which can mix the chemical | medical agent for mixing with raw | natural water of the attachment for mixing. (a)は、薬剤収容室に流動子を収容した状態を説明する略示斜視図、(b)は流動子の拡大斜視図である。(A) is a schematic perspective view explaining the state which accommodated the fluidizer in the chemical | medical agent storage chamber, (b) is an enlarged perspective view of a fluidizer. 螺旋流発生手段と軸方向放流手段とからなる乱流発生手段を例示する略示斜視図である。It is a schematic perspective view which illustrates the turbulent flow generation means which consists of a spiral flow generation means and an axial direction discharge means. (a),(b)は、本発明の好ましい一実施形態に係る混合用アタッチメントを示す側面図ある。(A), (b) is a side view which shows the attachment for mixing which concerns on preferable one Embodiment of this invention. 従来の混合用アタッチメントの一例を説明する部分破断側面図である。It is a partially broken side view explaining an example of the conventional attachment for mixing. (a)は、薬剤収容室の内部で流動子が遊動する他の状態を例示する略示斜視図、(a),(b)は、流動子の他の形状を例示する略示斜視図である。(A) is a schematic perspective view illustrating another state in which a fluidizer moves inside the medicine storage chamber, and (a) and (b) are schematic perspective views illustrating other shapes of the fluidizer. is there.

符号の説明Explanation of symbols

10 混合用アタッチメント
11 シャワー器具
12 シャワー水供給ホース
13 上流側流路(原水主流路)
14 下流側流路(原水主流路)
15 薬剤収容室
16 内側筒体
17 外側筒体
18 原水主流路
19 上流側閉塞部
20 下流側閉塞部
21 原水流入路(分岐水路)
22 流出路(分岐水路)
23 薬剤注入口
24 スライド注入口
25 開閉スライド部材
25a 開閉スライド部材の下端部(下方突出部分)
25b 開閉スライド部材の上端部(上方突出部分)
26 切り欠き凹部
27 遊嵌凸部
28 切り欠き凹溝
29 上方環状突壁
30 下方環状突壁
31 スライド案内溝
32 上方基盤
33 下方基盤
34 上流側連通孔
35 下流側連通孔
36 空気孔
37 流入口
38 収容室連通孔
39 流出口
40 収容室連通孔
43 スライド空気孔
50a,50b,50c 流動子
51 切欠き面
52 周方向放流口(螺旋流発生手段)
53 放流羽
54 軸方向放流口(軸方向放流手段)
55 流動子の端面
56 流動子の側周面
57 乱流発生手段
a 流動子の端面の径
b 流動子の側周面の高さ
c 円環状断面の薬剤収容室の径方向の幅
d 流動子の一対の端面の周縁を結ぶ対角方向の長さ
X 軸方向
Y 周方向
10 Mixing attachment 11 Shower fixture 12 Shower water supply hose 13 Upstream flow path (raw water main flow path)
14 Downstream channel (raw water main channel)
DESCRIPTION OF SYMBOLS 15 Drug storage chamber 16 Inner cylinder 17 Outer cylinder 18 Raw water main flow path 19 Upstream side blocking part 20 Downstream side blocking part 21 Raw water inflow path (branch water path)
22 Outflow channel (branch waterway)
23 medicine injection port 24 slide injection port 25 opening / closing slide member 25a lower end portion of the opening / closing slide member (lower protruding portion)
25b Upper end of the open / close slide member (upward protruding part)
26 Notch Concave 27 Free-Fitting Protrusion 28 Notch Concave Groove 29 Upper Ring Projection Wall 30 Lower Ring Projection Wall 31 Slide Guide Groove 32 Upper Base 33 Lower Base 34 Upstream Communication Hole 35 Downstream Communication Hole 36 Air Hole 37 Inlet 38 accommodation chamber communication hole 39 outlet 40 accommodation chamber communication hole 43 slide air holes 50a, 50b, 50c fluidizer 51 notched surface 52 circumferential outlet (spiral flow generating means)
53 Discharge feather 54 Axial discharge port (Axial discharge means)
55 End surface 56 of the fluidizer 56 Side surface 57 of the fluidizer Turbulence generating means a Diameter b of the end surface of the fluidizer Height c of the side surface of the fluidizer c Width in the radial direction of the drug containing chamber having an annular cross section d Fluidizer Diagonal length connecting the peripheral edges of a pair of end faces X axis direction Y circumferential direction

Claims (5)

内側筒体と外側筒体とを有し、前記内側筒体の内側を原水主流路とすると共に、前記内側筒体と前記外側筒体との間の中空部を、両端を上流側閉塞部と下流側閉塞部とで覆って円環状断面の薬剤収容室とし、該薬剤収容室に収容された混合用薬剤を原水に混合しつつ、該原水と共に流出させる混合用アタッチメントであって、
前記薬剤収容室には、前記原水主流路から分岐水路を経て流入する水の流れの作用によって当該薬剤収容室の内部で遊動する、比重の異なる少なくとも2種類の流動子が収容されており、
1種類以上の前記流動子は、重心に対し対称であり一対の端面の周縁を結ぶ対角方向の長さが前記薬剤収容室の径方向の幅より長くなっている混合用アタッチメント。
An inner cylindrical body and an outer cylindrical body, the inside of the inner cylindrical body as a raw water main flow path, a hollow portion between the inner cylindrical body and the outer cylindrical body, and both ends of the upstream cylindrical blocking section A medicine attachment chamber that is covered with a downstream blocking portion to form a medicine storage chamber having an annular cross section, and is mixed with the raw water while mixing the medicine for mixing contained in the medicine storage chamber with the raw water,
The drug storage chamber stores at least two kinds of fluidizers having different specific gravity, which float inside the drug storage chamber by the action of the flow of water flowing from the raw water main channel through the branch channel,
One or more kinds of the above-mentioned fluidizers are symmetric with respect to the center of gravity, and the diagonal length connecting the peripheral edges of the pair of end faces is longer than the radial width of the drug storage chamber.
前記流動子は、一対の端面と該端面の間の側周面とを備える高さの低い柱体形状を有していて、一方の端面を前記円環状断面の放射方向外側に向けた状態で前記薬剤収容室の内部に収容されており、円柱形状又は略円柱形状である請求項1記載の混合用アタッチメント。   The fluidizer has a low columnar shape including a pair of end surfaces and a side peripheral surface between the end surfaces, and one end surface is directed radially outward of the annular cross section. The mixing attachment according to claim 1, wherein the mixing attachment is accommodated in the medicine accommodating chamber and has a cylindrical shape or a substantially cylindrical shape. 前記柱体形状又は略円柱形状を有する流動子の端面の径aと、側周面の高さbとの比b/aが0.45〜0.9である請求項1又は2に記載の混合用アタッチメント。   The ratio b / a between the diameter a of the end face of the fluidizer having the columnar shape or the substantially cylindrical shape and the height b of the side peripheral surface is 0.45 to 0.9. Attachment for mixing. 前記円環状断面の薬剤収容室の径方向の幅cと前記柱体形状を有する流動子の側周面の高さbとの比b/cが0.75〜0.83である請求項1〜3のいずれかに記載の混合用アタッチメント。   The ratio b / c between the radial width c of the medicine container having the annular cross section and the height b of the side peripheral surface of the fluid body having the columnar shape is 0.75 to 0.83. The attachment for mixing in any one of -3. 請求項1〜4のいずれかに記載の混合用アタッチメントを一体として取り付けた薬剤散布器具。
The chemical | medical agent spraying instrument which attached the attachment for mixing in any one of Claims 1-4 integrally.
JP2006063230A 2006-03-08 2006-03-08 Attachment for mixing Expired - Fee Related JP4662867B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2006063230A JP4662867B2 (en) 2006-03-08 2006-03-08 Attachment for mixing

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006063230A JP4662867B2 (en) 2006-03-08 2006-03-08 Attachment for mixing

Publications (2)

Publication Number Publication Date
JP2007237083A JP2007237083A (en) 2007-09-20
JP4662867B2 true JP4662867B2 (en) 2011-03-30

Family

ID=38583153

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006063230A Expired - Fee Related JP4662867B2 (en) 2006-03-08 2006-03-08 Attachment for mixing

Country Status (1)

Country Link
JP (1) JP4662867B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI754565B (en) 2021-03-17 2022-02-01 源美股份有限公司 Sprinkler for spraying mixed liquid and clean water

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0681389U (en) * 1993-04-30 1994-11-22 巍 藤 Cosmetic elution device
JP2005152816A (en) * 2003-11-26 2005-06-16 Kao Corp Attachment for mixing
JP2006055222A (en) * 2004-08-17 2006-03-02 Kao Corp Shower agent for shower equipment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6451131A (en) * 1987-08-21 1989-02-27 Fuji Denki Seisakusho Kk Method and apparatus for stirring and mixing fluids
JPH08187454A (en) * 1995-01-08 1996-07-23 Masato Fukuhara Device for sprinkling chemical solution from sprinkling apparatus

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0681389U (en) * 1993-04-30 1994-11-22 巍 藤 Cosmetic elution device
JP2005152816A (en) * 2003-11-26 2005-06-16 Kao Corp Attachment for mixing
JP2006055222A (en) * 2004-08-17 2006-03-02 Kao Corp Shower agent for shower equipment

Also Published As

Publication number Publication date
JP2007237083A (en) 2007-09-20

Similar Documents

Publication Publication Date Title
CN111629818B (en) Foaming dispenser
TWI580385B (en) Shower head and cartridge
JP2011501696A (en) Method for filling dispensers and liquid additive containers
JP4662867B2 (en) Attachment for mixing
JP7075746B2 (en) shower head
US11712136B2 (en) Showerhead assembly with integrated soap-shampoo reservoir
JP4688454B2 (en) Mixing attachments and drug spreaders
CN210171795U (en) Cosmetic articles for use storage device that gondola water faucet was used
JP4259989B2 (en) Attachment for mixing
JP4162576B2 (en) Attachment for mixing
JP4467381B2 (en) Shower agent for shower equipment
JP4498055B2 (en) Attachment for mixing
JP2004042027A (en) Attachment for mixing
US2345275A (en) Douche appliance
JP2006159076A (en) Attachment for mixing
JP4169684B2 (en) Attachment for mixing
AU2013318406A1 (en) Hose-end sprayer
JPH049007Y2 (en)
JP2006150293A (en) Attachment for mixing
KR102341861B1 (en) A shower device including water fan
WO2020042499A1 (en) Flushing system and intelligent toilet bowl cover
JP5778710B2 (en) Shower equipment
JP2014083411A (en) Shower head
JP4756779B2 (en) Attachment for mixing
KR102053416B1 (en) Cleaning material supply device

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090109

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20101216

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110104

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110104

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140114

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees